Impact of Decentralized Clinical Trial Methodologies on Alzheimer’s research

The Decentralized Trials and Research Alliance represents over 120 organizational members including regulatory authorities, biopharmaceutical companies, technology companies, patient advocates, clinical trial sites, and service companies. Four priority areas have been identified to accelerate the adoption of decentralized methodologies where appropriate in clinical research. Within these four priority areas, 12 initiatives were launched.